当前位置: 首页 > 详情页

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [3]Capital Med Univ, Beijing Tiantan Hosp, Dept Radiat Therapy, Beijing, Peoples R China; [4]China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [5]Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [6]Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Pathol, Beijing, Peoples R China; [7]Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing, Peoples R China; [8]Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China; [9]Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [10]Capital Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth & Family Med, Beijing, Peoples R China
出处:
ISSN:

关键词: high-grade glioma young adult radiation temozolomide survival

摘要:
Purpose: Age is a major prognostic factor for malignant gliomas. However, few studies have investigated the management of gliomas in young adults. We determined the role of survival and treatment in young adults with advanced gliomas in a large population from the Chinese Glioma Genome Atlas (CGGA). Methods: This study included 726 adults (age >= 18) with histologically proven anaplastic glioma or glioblastoma multiforme (GBM). The overall and progression-free survival was determined in young (age < 50) and older groups (age >= 50). Results: The study included an older group (OP) of 264 patients and a younger group (YP) of 462patients. In the OP group with GBM and anaplastic glioma, patients treated with RT combined with temozolomide (TMZ) manifested significantly longer OS and PFS compared with patients assigned to RT alone (P < 0.05). In contrast, the YP group diagnosed with anaplastic glioma failed to show any survival advantage with RT plus TMZ compared with RT alone. Conclusions: We observed no survival benefit in young adults (age < 50) with anaplastic glioma when treated with TMZ combined with RT. Our findings warrant further investigation of younger patients diagnosed with anaplastic glioma treated with radiotherapy plus TMZ chemotherapy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 3 区 细胞生物学
最新[2023]版:
JCR分区:
出版当年[2014]版:
Q1 ONCOLOGY Q1 CELL BIOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [4]China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [8]Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院